-transparent.png){kind=logo}
Recently there has been an increased awareness of a possible link between the use of purine nucleoside analogues and myelodysplasia. We report the case of a patient who developed myelodysplasia with complex cytogenetic changes after receiving fludarabine. We review the literature, discuss the possible links between myelodysplasia and nucleoside analogues and putative mechanisms for secondary neoplasia.
| UI | MeSH Term | Description | Entries |
|---|
Related Publications
B J Hennessy, and
S Ryley, and
A Kasprzyk, and
C D Reid
June 1997,
Clinical and laboratory haematology,
B J Hennessy, and
S Ryley, and
A Kasprzyk, and
C D Reid
September 1995,
Annals of oncology : official journal of the European Society for Medical Oncology,
B J Hennessy, and
S Ryley, and
A Kasprzyk, and
C D Reid
August 2006,
Expert opinion on pharmacotherapy,
B J Hennessy, and
S Ryley, and
A Kasprzyk, and
C D Reid
July 2014,
British journal of haematology,
B J Hennessy, and
S Ryley, and
A Kasprzyk, and
C D Reid
September 1994,
Postgraduate medical journal,
B J Hennessy, and
S Ryley, and
A Kasprzyk, and
C D Reid
May 2001,
Journal of clinical pathology,
B J Hennessy, and
S Ryley, and
A Kasprzyk, and
C D Reid
January 2002,
Haematologia,
B J Hennessy, and
S Ryley, and
A Kasprzyk, and
C D Reid
June 2009,
Health technology assessment (Winchester, England),
B J Hennessy, and
S Ryley, and
A Kasprzyk, and
C D Reid
November 2006,
Haematologica,
B J Hennessy, and
S Ryley, and
A Kasprzyk, and
C D Reid
September 1999,
British journal of haematology,
